Cell culture models for SARS-CoV-2 infectivity and systemic complications
COVID-19 was declared by WHO as a pandemic since March 2020. The vaccination program has been implemented worldwide. Specific antiviral drugs such as remdesivir, molnupiravir and ritonavir-based nirmatrelvir were effective against SARS-CoV-2 infection. However, the new SARS-CoV-2 variants have been...
Main Authors: | Khanit Sa-ngiamsuntorn, Piyanoot Thongsri, Yongyut Pewkliang, Adisak Wongkajornsilp |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Pharmacy, Mahidol University
2022-07-01
|
Series: | Pharmaceutical Sciences Asia |
Subjects: | |
Online Access: | https://pharmacy.mahidol.ac.th/journal/_files/2022-49-4_1.pdf |
Similar Items
-
Immortalized hepatocyte-like cells: A competent hepatocyte model for studying clinical HCV isolate infection
by: Yongyut Pewkliang, et al.
Published: (2024-01-01) -
Avoiding culture shock with the SARS-CoV-2 spike protein
by: Benjamin G Hale
Published: (2021-05-01) -
Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation
by: Mart M Lamers, et al.
Published: (2021-04-01) -
In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease
by: Natalie Heinen, et al.
Published: (2021-04-01) -
Lung Organoids as Model to Study SARS-CoV-2 Infection
by: Li Peng, et al.
Published: (2022-09-01)